LE300 – 1 mg

Brand:
Cayman
CAS:
274694-98-3
Storage:
-20
UN-No:
Non-Hazardous - /

LE300 is a dopamine D1-like receptor antagonist (Kis = 1.9 and 7.5 nM in CHO cell membranes expressing human dopamine D1 and D5 receptors, respectively) and antagonist of the serotonin (5-HT) receptor subtype 5-HT2A (pA2 = 8.32 in a rat tail artery assay).{45983,45984} It is selective for dopamine D1 and D5 over D2L and D4.4 receptors (Kis = 44.7 and 109 nM, respectively).{45983} LE300 inhibits the conditioned avoidance response in the pole-jump test in rats (ED50 = 0.94 mg/kg), which is predictive for antipsychotic-like activity.{45985} It also reduces locomotor activity in the open field test in rats (ED50 = 0.74 mg/kg).  

 

Available on backorder

SKU: 29856 - 1 mg Category:

Description

A dopamine D1-like receptor antagonist (Kis = 1.9 and 7.5 nM in CHO cell membranes expressing human dopamine D1 and D5 receptors, respectively) and 5-HT2A receptor antagonist (pA2 = 8.32 in a rat tail artery assay); selective for dopamine D1 and D5 over D2L and D4.4 receptors (Kis = 44.7 and 109 nM, respectively); inhibits the conditioned avoidance response in the pole jump test in rats (ED50 = 0.94 mg/kg), which is predictive for antipsychotic-like activity; reduces locomotor activity in the open field test in rats (ED50 = 0.74 mg/kg)


Formal name: 6,7,8,9,14,15-hexahydro-7-methyl-5H-indolo[3,2-f][3]benzazecine

Synonyms: 

Molecular weight: 290.4

CAS: 274694-98-3

Purity: ≥98%

Formulation: A solid